Camlin Fine Sciences' stock has surged 145% from April's low of ₹128 to ₹312, reaching an all-time high of ₹324. A positive profit report and shutdown of unprofitable plants are boosting growth, with projections of continued momentum in the Blends and Aroma segments.
2 min read02:22 PM ISTScientist Sharmila Bhattacharya explains why cross-country collaboration is key to space missions such as Axiom-4
6 min read14 Jun 2025A UK study challenges the Big Bang theory, proposing that the universe exists inside a black hole. The new model suggests a gravitational collapse created the universe.
2 min read12 Jun 2025The Axiom-4 mission delayed again, this time due to an LOx leak, according to SpaceX and ISRO. This means that Indian astronaut Shubhanshu Shukla's history-making mission is delayed till repairs are completed. Here's all you need to know…
2 min read11 Jun 2025There are 182 clinical trials for Alzheimer’s treatments under way in 2025—an 11% increase on the previous year—testing 138 different drugs, of which 12 are set to complete their final “phase 3” trials this year.
6 min read4 Jun 2025Suven Life Sciences shares have surged 98.3% from ₹120 to ₹238 over 22 trading sessions, driven by a recent ₹857 crore fundraising for R&D. Despite widening losses, investor optimism remains strong due to the company's CNS-focused drug pipeline and long-term growth potential.
2 min read4 Jun 2025A study reveals that gold and precious metals from Earth's core may be seeping into the mantle and reaching the surface during volcanic activity. This challenges the belief that Earth's gold is entirely trapped deep below.
1 min read3 Jun 2025Researchers in Spain have discovered a pebble with a Neanderthal fingerprint, suggesting they created symbolic art. This 43,000-year-old find supports the idea that Neanderthals had imaginative thinking.
1 min read31 May 2025Stock to buy for short-term: Strides Pharma Science share price has rallied 19% in one month and 25% in three months. The small-cap stock is up 10% YTD and jumped 94% in the past one year. Strides Pharma Science shares have delivered multibagger returns of 354% in two years and 310% in five years.
2 min read30 May 2025Stocks to buy: Rajesh Palviya has recommended to buy, hold, and accumulate Chennai Petroleum Corporation Ltd, One 97 Communications Ltd (Paytm), and Strides Pharma Science Ltd.
3 min read30 May 2025